False
September 15, 2026
4 min read
The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics
September 10, 2026
8 min read
Ali Tavassoli explains how cyclic peptides and new discovery tools are opening up once-inaccessible biology
September 8, 2026
4 min read
Scientific progress alone isn't enough, says Miguel Forte, who argues that reimbursement and patient access will shape the next decade of cell and gene therapy
September 4, 2026
2 min read
Peng Lu argues that small molecules remain indispensable as AI transforms drug development
False
2 Topic Commentaries
Musings from The Power List: Dajun Yang
Dajun Yang, MD, PhD
Oncology drug development; targeted small-molecule therapeutics
•Ascentage Pharma
Dajun Yang, MD, PhD
Protein degradation; oncology drug discovery
•Ascentage Pharma
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.